Filtered By:
Condition: Aortic Stenosis
Procedure: Heart Valve Surgery

This page shows you your search results in order of date. This is page number 17.

Order by Relevance | Date

Total 839 results found since Jan 2013.

Transcatheter aortic valve implantation results are not superimposable to surgery in patients with aortic stenosis at low surgical risk
CONCLUSIONS: TAVI and SVAR in the treatment of AS in the patients at low surgical risk are not superimposable. In particular, if 30-day and 1-year mortality, major bleeding and acute kidney injury were significantly lower for TAVI, the need of new PM implantation and paravalvular leak were significantly lower in SAVR. Consequently, we suggest the need of more trials to evaluate the effectiveness of TAVI as routine therapeutic procedure in the treatment of patients with low surgical risk AS.PMID:34622437 | DOI:10.5603/CJ.a2021.0114
Source: Cardiology Journal - October 8, 2021 Category: Cardiology Authors: Maria Cristina Acconcia Marco Alfonso Perrone Domenico Sergi Marco Di Luozzo Massimo Marchei Pasquale De Vico Antonio Sili Scavalli Giuseppe Pannarale Marcello Chiocchi Carlo Gaudio Francesco Romeo Quintilio Caretta Francesco Barill à Source Type: research

TAVR for Bicuspid Aortic Valve Stenosis
This registry-based cohort study compared rates of mortality and stroke at 30 days and 1 year among patients at low surgical risk with bicuspid vs tricuspid aortic stenosis undergoing transcatheter aortic valve replacement (TAVR).
Source: JAMA - September 21, 2021 Category: General Medicine Source Type: research

Clinical results and 30-day outcomes of self-expanding transcatheter aortic valves: comparative case-matched analysis of CoreValve < sup > ® < /sup > versus ACURATE neo ™
CONCLUSION: Both self-expandable prostheses showed good postoperative hemodynamic performance with a low incidence of severe paravalvular leakage, all- cause mortality, and comparable clinical outcomes.PMID:34472999 | DOI:10.1177/02676591211042562
Source: Perfusion - September 2, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Borko Ivanov Kaveh Eghbalzadeh Ilija Djordjevic Mohamed Zeriouh Stephen Gerfer Christopher Gaisendrees Anton Sabashnikov Christian Rustenbach Parwis Rahmanian Ferdinand Kuhn-Regnier Navid Mader Matti Adam Stephan Baldus Thorsten Wahlers Elmar Kuhn Source Type: research

Risk of Stroke After Transcatheter Aortic Valve Implantation: Epidemiology, Mechanism, and Management
Conclusions: The overall evidences confirm similar or lower rate of stroke in TAVI versus SAVR. Risk predictors for acute stroke after TAVI are generally related to procedural factors, whereas late stroke is mainly associated with patient characteristics, with a variable impact on cognitive function. The optimal choice for the antithrombotic treatment in TAVI for stroke prevention is yet to be determined. Current data do not support routine use of cerebral embolic protection devices during TAVI.
Source: American Journal of Therapeutics - September 1, 2021 Category: Drugs & Pharmacology Tags: Therapeutic Advances Source Type: research

New frontiers for improving outcomes after transcatheter aortic valve implantation: the role of the conduction system and the impact of pacemakers
Transcatheter aortic valve implantation (TAVI) is at least as safe and effective as surgical aortic valve replacement (SAVR) in patients with severe symptomatic aortic stenosis for the endpoints of all-cause mortality, stroke and heart failure hospitalizations across the spectrum of surgical risk1,2. Despite iterative advances in technology and refinements in procedural technique, conduction disturbances are not infrequent and occur more commonly after TAVI than after surgery. In the most recent low-risk randomized trials2,3 comparing TAVI to SAVR, the rates of permanent pacemaker implantation (PPI) were 6.6% with the ball...
Source: Heart Rhythm - August 18, 2021 Category: Cardiology Authors: Yousif Ahmad, Raj Makkar Source Type: research

Advancements in Transcatheter Aortic Valve Implantation: A Focused Update
Medicina (Kaunas). 2021 Jul 14;57(7):711. doi: 10.3390/medicina57070711.ABSTRACTTranscatheter aortic valve implantation (TAVI) has become the leading technique for aortic valve replacement in symptomatic patients with severe aortic stenosis with conventional surgical aortic valve replacement (SAVR) now limited to patients younger than 65-75 years due to a combination of unsuitable anatomies (calcified raphae in bicuspid valves, coexistent aneurysm of the ascending aorta) and concerns on the absence of long-term data on TAVI durability. This incredible rise is linked to technological evolutions combined with increased opera...
Source: Medicina (Kaunas) - August 6, 2021 Category: Universities & Medical Training Authors: Niccol ò Ciardetti Francesca Ciatti Giulia Nardi Francesca Maria Di Muro Pierluigi Demola Edoardo Sottili Miroslava Stolcova Francesca Ristalli Alessio Mattesini Francesco Meucci Carlo Di Mario Source Type: research